News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NextDocs and Novella to Present on eTMF at Drug Information Association 2013


6/20/2013 6:33:23 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CONSHOHOCKEN, Pa., June 19, 2013 /PRNewswire/ -- NextDocs announced today that it will co-present with Novella, a full service clinical research organization, at DIA 2013, the Drug Information Association annual meeting and conference. The companies will present case studies that explore best practices for making the transition from paper trial master file to electronic trial master file (eTMF) systems.

Sharon Ames, enterprise program director at NextDocs will present alongside Krystyna Kowalczyk, executive vice president of clinical operations at Novella, in a session entitled, "That Awkward Stage: Transitioning from Paper Trial Master File to eTMF." The session will examine how to structure a paper-to-electronic transition that incorporates the needs of ongoing studies while also meeting regulatory needs and reducing operational impacts.

DIA 2013, the 49th annual meeting and conference of the DIA, is the largest multidisciplinary event for the pharmaceutical and life sciences industry, focusing on advancing therapeutic innovation and regulatory science. The DIA 2013 conference takes place at the Convention and Exhibition Center in Boston from June 23 - 27, 2013.

NextDocs and Novella's session, "That Awkward Stage: Transitioning from Paper Trial Master File to eTMF," will take place on Monday, June 24, 2013 at 2:30 p.m. Additionally, NextDocs will be demonstrating its solutions at the DIA conference in booth #1722.

For more information on DIA 2013, visit www.diahome.org. For more information on NextDocs, visit www.nextdocs.com.

CONTACT:
Dan Cahill
1-917-617-0106
dcahill@roaringpr.com

SOURCE NextDocs



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES